The Application of Artificial Intelligence in Prostate Cancer Management—What Improvements Can Be Expected? A Systematic Review
Authors:
- Ronan ThenaultRTRonan Thenault
- Kevin KaulanjanKKKevin Kaulanjan
- Thomas DardeTDThomas Darde
- Nathalie Rioux-LeclercqNRNathalie Rioux-Leclercq
- Karim BensalahKBKarim Bensalah
- Marie MermierMMMarie Mermier
- Zine-Eddine KheneZKZine-Eddine Khene
- Benoit PeyronnetBPBenoit Peyronnet
- Shahrokh ShariatSSShahrokh Shariat
- Benjamin PradèreBPBenjamin Pradère
- Romain MathieuRMRomain Mathieu
Open Access
- 15 September 2020
- journal article
- review article
- Published by MDPI AG in Applied Sciences
- Vol. 10 (18) , 6428
Abstract
Artificial Intelligence (AI) is progressively remodeling our daily life. A large amount of information from “big data” now enables machines to perform predictions and improve our healthcare system. AI has the potential to reshape prostate cancer (PCa) management thanks to growing applications in the field. The purpose of this review is to provide a global overview of AI in PCa for urologists, pathologists, radiotherapists, and oncologists to consider future changes in their daily practice. A systematic review was performed, based on PubMed MEDLINE, Google Scholar, and DBLP databases for original studies published in English from January 2009 to January 2019 relevant to PCa, AI, Machine Learning, Artificial Neural Networks, Convolutional Neural Networks, and Natural-Language Processing. Only articles with full text accessible were considered. A total of 1008 articles were reviewed, and 48 articles were included. AI has potential applications in all fields of PCa management: analysis of genetic predispositions, diagnosis in imaging, and pathology to detect PCa or to differentiate between significant and non-significant PCa. AI also applies to PCa treatment, whether surgical intervention or radiotherapy, skills training, or assessment, to improve treatment modalities and outcome prediction. AI in PCa management has the potential to provide a useful role by predicting PCa more accurately, using a multiomic approach and risk-stratifying patients to provide personalized medicine.Keywords
This publication has 121 references indexed in Scilit:
- Longitudinal analysis of pain in patients with metastatic prostate cancer using natural language processing of medical record textJournal of the American Medical Informatics Association, 2013
- Predicting outcomes in radiation oncology—multifactorial decision support systemsNature Reviews Clinical Oncology, 2012
- Radiomics: the process and the challengesMagnetic Resonance Imaging, 2012
- Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRIPhysics in Medicine & Biology, 2012
- Pre-Operative Prediction of Advanced Prostatic Cancer Using Clinical Decision Support Systems: Accuracy Comparison between Support Vector Machine and Artificial Neural NetworkKorean Journal of Radiology, 2011
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2011
- Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent modelsInternational Urology and Nephrology, 2010
- Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRIPhysics in Medicine & Biology, 2010
- Application of Artificial Intelligence to the Management of Urological CancerJournal of Urology, 2007
- What is a support vector machine?Nature Biotechnology, 2006